Literature DB >> 33572710

Sialic Acids and Their Influence on Human NK Cell Function.

Philip Rosenstock1, Thomas Kaufmann1.   

Abstract

Sialic acids are sugars with a nine-carbon backbone, present on the surface of all cells in humans, including immune cells and their target cells, with various functions. Natural Killer (NK) cells are cells of the innate immune system, capable of killing virus-infected and tumor cells. Sialic acids can influence the interaction of NK cells with potential targets in several ways. Different NK cell receptors can bind sialic acids, leading to NK cell inhibition or activation. Moreover, NK cells have sialic acids on their surface, which can regulate receptor abundance and activity. This review is focused on how sialic acids on NK cells and their target cells are involved in NK cell function.

Entities:  

Keywords:  CD56; NCAM; NK cells; NKG2D; NKp44; Nkp46; Siglecs; sialic acids; sialylation; sialyltransferases

Year:  2021        PMID: 33572710      PMCID: PMC7911748          DOI: 10.3390/cells10020263

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  155 in total

1.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

Authors:  J Munday; S Kerr; J Ni; A L Cornish; J Q Zhang; G Nicoll; H Floyd; M G Mattei; P Moore; D Liu; P R Crocker
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis.

Authors:  G Ferlazzo; C Semino; G Melioli
Journal:  Immunol Lett       Date:  2001-02-01       Impact factor: 3.685

3.  Enzymatic synthesis of sialic acid 9-phosphates.

Authors:  S ROSEMAN; G W JOURDIAN; D WATSON; R ROOD
Journal:  Proc Natl Acad Sci U S A       Date:  1961-07-15       Impact factor: 11.205

Review 4.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

5.  Binding affinities of NKG2D and CD94 to sialyl Lewis X-expressing N-glycans and heparin.

Authors:  Koji Higai; Chiho Suzuki; Yuzo Imaizumi; Xin Xin; Yutaro Azuma; Kojiro Matsumoto
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

6.  Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.

Authors:  Mostafa Jarahian; Carsten Watzl; Yasmin Issa; Peter Altevogt; Frank Momburg
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

7.  Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.

Authors:  Sara Meril; Ortal Harush; Yishai Reboh; Tatyana Matikhina; Tilda Barliya; Cyrille J Cohen
Journal:  Mol Carcinog       Date:  2020-05-11       Impact factor: 4.784

Review 8.  Dendritic cells: a spot on sialic Acid.

Authors:  Hélio J Crespo; Joseph T Y Lau; Paula A Videira
Journal:  Front Immunol       Date:  2013-12-27       Impact factor: 7.561

9.  Impact of polysialylated CD56 on natural killer cell cytotoxicity.

Authors:  Jeannette M Moebius; Darius Widera; Juergen Schmitz; Christian Kaltschmidt; Christoph Piechaczek
Journal:  BMC Immunol       Date:  2007-08-06       Impact factor: 3.615

Review 10.  Features of Memory-Like and PD-1(+) Human NK Cell Subsets.

Authors:  Mariella Della Chiesa; Silvia Pesce; Letizia Muccio; Simona Carlomagno; Simona Sivori; Alessandro Moretta; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2016-09-14       Impact factor: 7.561

View more
  7 in total

Review 1.  N-Glycosylation and Inflammation; the Not-So-Sweet Relation.

Authors:  Barbara Radovani; Ivan Gudelj
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 2.  The intriguing roles of Siglec family members in the tumor microenvironment.

Authors:  Kui-Ying Jiang; Li-Li Qi; Fu-Biao Kang; Ling Wang
Journal:  Biomark Res       Date:  2022-04-13

Review 3.  Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Mol Ther Oncolytics       Date:  2021-11-29       Impact factor: 7.200

Review 4.  Polysialic Acid in the Immune System.

Authors:  Tania M Villanueva-Cabello; Lya D Gutiérrez-Valenzuela; Roberta Salinas-Marín; Delia V López-Guerrero; Iván Martínez-Duncker
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

5.  Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity.

Authors:  Manuel M Vicente; Inês Alves; Joana Gaifem; Cláudia S Rodrigues; Ângela Fernandes; Ana M Dias; Jerko Štambuk; Tea Petrović; Pedro Oliveira; Frederico Ferreira-da-Silva; Adriana Soares; Nair Seixas; Tiago Teixeira; Luis Malheiro; Miguel M Abreu; Gordan Lauc; Rui Sarmento E Castro; Salomé S Pinho
Journal:  Eur J Immunol       Date:  2022-04-04       Impact factor: 6.688

Review 6.  Neuraminidases-Key Players in the Inflammatory Response after Pathophysiological Cardiac Stress and Potential New Therapeutic Targets in Cardiac Disease.

Authors:  Maren Heimerl; Thomas Gausepohl; Julia H Mueller; Melanie Ricke-Hoch
Journal:  Biology (Basel)       Date:  2022-08-17

7.  Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action.

Authors:  Charles L Hitchcock; Stephen P Povoski; Cathy M Mojzisik; Edward W Martin
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.